Drugs Made In America Acquisition Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DMAAR | APUS | ANIP | AMRX | ACXP | INM | |
|---|---|---|---|---|---|---|
| Market cap | — | 6.10M | 1.66B | 6.68B | 6.12M | 7.25M |
| P/E (TTM) | — | — | 15.6 | 39.1 | — | — |
| Forward P/E | — | — | 7.1 | 16.1 | -0.6 | -0.2 |
| Price/book | -0.4 | 6.2 | 2.6 | 186.2 | 0.6 | 6.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | — | −77.80% | −24.00% | +87.30% | −84.22% | −38.60% |
| Today | 0.00% | −7.97% | +0.01% | −0.36% | −5.98% | −0.75% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All DMAAR news ›Price to earnings forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU
TradingView Drugs Made In America Acquisition Corp. Price to earnings forward of Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition II Corp. News — NASDAQ:DMII
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.